The West Nile virus assembly process evades the conserved antiviral mechanism of the interferon-induced MxA protein  by Hoenen, Antje et al.
The West Nile virus assembly process evades the conserved antiviral
mechanism of the interferon-induced MxA protein
Antje Hoenen a,1, Leah Gillespie d,e, Garry Morgan c, Peter van der Heide c,
Alexander Khromykh a,b, Jason Mackenzie d,e,n
a School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia
b Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Australia
c Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia
d Department of Microbiology, La Trobe University, Melbourne, Australia
e Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
a r t i c l e i n f o
Article history:
Received 11 June 2013
Returned to author for revisions
28 June 2013
Accepted 3 October 2013
Available online 22 October 2013
Keywords:
Innate immunity
Interferon-induced antiviral protein
West Nile virus
MxA
Virus assembly
a b s t r a c t
Flaviviruses have evolved means to evade host innate immune responses. Recent evidence suggests this
is due to prevention of interferon production and signaling in ﬂavivirus-infected cells. Here we show that
the interferon-induced MxA protein can sequester the West Nile virus strain Kunjin virus (WNVKUN)
capsid protein in cytoplasmic tubular structures in an expression-replication system. This sequestering
resulted in reduced titers of secreted WNVKUN particles. We show by electron microscopy, tomography
and 3D modeling that these cytoplasmic tubular structures form organized bundles. Additionally we
show that recombinant ER-targeted MxA can restrict production of infectious WNVKUN under conditions
of virus infection. Our results indicate a co-ordinated and compartmentalized WNVKUN assembly process
may prevent recognition of viral components by MxA, particularly the capsid protein. This recognition
can be exploited if MxA is targeted to intracellular sites of WNVKUN assembly. This results in further
understanding of the mechanisms of ﬂavivirus evasion from the immune system.
Crown Copyright & 2013 Published by Elsevier Inc. All rights reserved.
Introduction
Flaviviruses are a family of pathogenic, enveloped positive-
sense RNA viruses that cause a range of infections in man e.g.
yellow fever, encephalitis, dengue (by species of the Flavivirus
genus) and hepatitis C (by hepatitis C virus). Many hundreds of
thousands of deaths associated with ﬂavivirus infections occur
each year, many of which are unavoidable with current vaccine
and therapeutic strategies. Mortality is caused by both acute (e.g.
encephalitis and hemorrhage) and chronic-infections (e.g. liver
cirrhosis), indicating the diverse nature of disease progression.
West Nile virus (strain Kunjin, WNVKUN), Japanese encephalitis
virus (JEV) and Murray Valley encephalitis (MVE) are all endemic
within Australia and the latter two viruses cause the majority of
virus-induced encephalitis within this country. The recent emer-
gence of WNV strain New York 99 infections in the United States
has also presented a considerable concern as 28,906 cases with
1121 fatalities have been observed (Centres for Disease Control and
Prevention West Nile virus surveillance program 1999–2008).
Previous research has indicated that ﬂavivirus infections are
inhibited by the innate immune system; however once these viruses
are established within cells this response is limited. The type I IFNs
appear to inhibit infection by preventing the transcription of minus-
strand RNA (Diamond et al., 2000). However, it has not been
established whether this is a consequence of inhibiting translation of
the incoming infectious RNA, thus also preventing formation of the
replication complex. A requirement for type-I IFN in ﬂavivirus
clearance was exempliﬁed in mice deﬁcient for the IFN-α receptor,
where challenge with a lethal low dose of MVE virus resulted in a
drastically increased susceptibility and 100% mortality (Lobigs et al.,
2003). Additionally, these mice also succumbed to the lethal challenge
signiﬁcantly quicker than control mice (Lobigs et al., 2003). However,
efﬁcient replication of WNVKUN replicons was not inhibited by the
addition of IFN-α, even at levels that abolished the replication of
Hepatitis C virus (HCV) replicons (Guo et al., 2005, 2003). It also
appeared that the activation of IFN-α-induced gene expression was
hampered in the WNVKUN replicon cells (Guo et al., 2005, 2003; Liu
et al., 2004, 2005). Conversely, IFN-γ appears to inhibit ﬂavivirus
infection and replication by stimulating the generation of proinﬂam-
matory molecules and other antiviral molecules including nitric oxide
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(Lin et al., 1997). Mice deﬁcient for IFN-γ or nitric oxide production
showed increased mortality and morbidity upon infection with the
ﬂavivirus MVE (Lobigs et al., 2003).
Many recent reports have showed that both IFN production and
signaling are drastically compromised in ﬂavivirus-infected cells (Liu
et al., 2004; Munoz-Jordan et al., 2003). A phenotype that appears to
be mediated via expression of the small hydrophobic non-structural
proteins NS2A, NS4A and NS4B (Munoz-Jordan et al., 2003), although
recent results with WNVKUN non-structural proteins have indicated
that all of these, except NS1, are capable of inhibiting IFN signaling (Liu
et al., 2005). Other ﬂaviviruses have also shown to inﬂuence the host
cells' capacity to respond to IFN with differing degrees. Our recent
observations have suggested that WNV can manipulate the intracel-
lular distribution of cholesterol, such that cholesterol-rich microdo-
mains facilitating IFN-mediated signaling cascades are dispersed and
do not support immune competency (Mackenzie et al., 2007). In
addition to inhibiting IFN production and signaling we have shown
that membrane alterations induced by ﬂaviviruses also provide partial
protection against the IFN-induced antiviral protein MxA (Hoenen
et al., 2007; Overby et al., 2010).
The human MxA protein is a 78 kDa protein that is speciﬁcally
induced by type-I and type-III IFNs and localizes solely to the
cytoplasm of cells (Stertz et al., 2006). The MxA proteins have a high
intrinsic ability to self-assemble into highly ordered oligomers
(Daumke et al., 2010; Gao et al., 2010; Kochs et al., 2002). This
oligomerization appears to have some requirement for GTP, nucleo-
tides and salt and provides an extremely stable conﬁguration for MxA.
One of the striking features observed of human MxA is its ability to
prevent active replication and thus infection of cells by invading
viruses. In particular MxA displays some speciﬁcity towards negative-
stranded RNA viruses belonging to the families Orthomyxoviridae
(Frese et al., 1995; Marschall et al., 2000; Pavlovic et al., 1992, 1990),
Paramyxoviridae (Schneider-Schaulies et al., 1994; Schnorr et al., 1993),
Rhabdoviridae (Pavlovic et al., 1990) and Bunyaviridae (Frese et al.,
1996; Kanerva et al., 1996; Kochs et al., 2002; Reichelt et al., 2004). In
addition, MxA has also shown to have some antiviral properties
against plus-stranded RNA viruses (Chieux et al., 2001; Landis et al.,
1998), double-stranded RNA viruses (Mundt, 2007), and some DNA
viruses (Gordien et al., 2001; Netherton et al., 2009). In particular the
antiviral activity appears directed towards steps of viral RNA transcrip-
tion and/or the direct interaction with pre-formed or forming nucleo-
capsids. Recent structural data has shown that MxA oligerimerizes into
ring-like structures that may form around the viral nucleocapsid, thus
inhibiting replicative function (Gao et al., 2011). The only investigations
of MxA on the family Flaviviridae is with HCV and WNVKUN, where it
was observed that replication of the HCV andWNVKUN still occurred in
the presence of MxA (Frese et al., 2001; Hoenen et al., 2007).
In this report we show that the human MxA protein has the
intrinsic ability to prevent WNVKUN infection via sequestration of
the WNVKUN capsid protein; however we propose that WNVKUN
has evolved a replication and assembly strategy that prevents detec-
tion by MxA. More compelling we show that retargeting MxA
expression from cytoplasmic inclusions to the endoplasmic reticulum
(ER) during WNVKUN replication can signiﬁcantly hamper the forma-
tion and spread of infectious WNVKUN virions. These observations
open avenues in the development of antiviral therapies against this
highly pathogenic family of viruses.
Results
Expression of MxA from the WNVKUN replicon impairs the recovery
of infectious VLPs
Previously we showed that WNVKUN is insensitive to the ascribed
antiviral properties of the human MxA protein (Hoenen et al., 2007).
In part, this is due to the dramatic membrane rearrangements that
are induced by WNVKUN to facilitate efﬁcient replication
(Mackenzie, 2005; Westaway et al., 1997a, 1997b). In order to
further understand the antiviral properties of the human MxA
proteins we expressed the human MxA protein from the WNVKUN
replicon (KUNrepMxA). The replicon was subsequently transfected
into a WNVKUN packaging cell line (tet-KUNCprME) and the
Fig. 1. Expression of the human MxA protein from a WNVKUN replicon in a
packaging cell line impairs VLP production. (A) Quantitation of the recovered
medium reveals that KUNrepMxA produces signiﬁcantly less VLPs than KUNrepβ-
gal as assayed by an immunoﬂuoresecent focus assay and calculation of infectious
particles per ml. Results were collated after duplicate analysis from replicate
experiments (KUNrepMxA n¼5; KUNrepβ-gal n¼3). Statistical analysis was per-
formed using Prism 6 and students t-test. (B) Comparison of replication kinetics
between KUNrepMxA and KUNrepβ-gal reveals no apparent differences. RNA
replication was assessed by real time-PCR (performed in duplicate) and (C) protein
production determined by western blot for the WNVKUN NS3 protein after 24, 48
and 72 h post-infection of Vero cells with the recovered VLPs.
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resulting supernatant containing VLPs was collected for analysis.
Surprisingly, we found that the recovered titers were 1–1.5 logs
lower when compared to titers recovered from KUNrepβ-gal
replicons (Fig. 1A). To investigate whether this was due to
differences in replication efﬁciencies between the two replicons
we re-infected Vero cells with puriﬁed VLPs. Replication efﬁciency
was subsequently assessed by real-time PCR and western blot
analysis (Fig. 1B and C). It is evident that both replicons replicated
to similar levels after re-infection (Fig. 1B). Additionally, protein
translation did not appear to be impeded or altered between the
two replicons (Fig. 1C). In fact it appeared that replication of
KUNrepMxA occurred earlier that KUNrepβ-gal, although both
replicons were observed to replicate to similar levels by 48 h post-
electroporation (p.e.).
Strikingly, IF analysis of the KUNrepMxA-transfected tet-
KUNCprME BHK cells with antibodies to the cmyc-tagged MxA
protein revealed the presence of large ﬁbrillar aggregates in the
cytoplasm (Fig. 2A–D). These aggregates were vastly different to
those observed during transient expression of MxA from a cDNA
expression plasmid and when expressed stably within the VMxA
cells (Fig. 2E and F). The ﬁbrillar aggregates were observed to
radiate from the perinuclear region to the periphery of the cell in a
sinuous disorganized manner. In addition the ﬁbrils appeared to
differ in their thickness (compare Fig. 2C and D for example),
which may represent different amounts of or degrees of oligomer-
ization of MxA in these cells. Interestingly, similar aggregates have
been previously observed during infection of MxA expressing cells
with La Crosse virus (LACV). It was previously observed that MxA
binds and relocates the LACV nucleocapsid (N) protein into
membrane-associated, large perinuclear complexes, comprised of
oligomeric MxA/N aggregates (Kochs et al., 2002; Reichelt et al.,
2004).
MxA appears to induce the sequestering of the WNVKUN C protein into
perinuclear aggregates, but not the other WNVKUN structural proteins
To determine the speciﬁc nature of the large ﬁbrillar aggregates
we immuno-labeled KUNrepMxA transfected tet-KUNCprME BHK
cells with antibodies to cmyc-tagged MxA (either anti-cmyc or anti-
MxA antibodies), and the WNVKUN C, envelope (E) and prM proteins.
Fig. 2. Expression of the human MxA protein from the KUNrepMxA replicon in a packaging cell line results in the formation of large cytoplasmic aggregates. (Panels A–D) IF
analysis of replicon electroporated tet-KUNCprME BHK cells reveals redistribution of the expressed MxA protein into ﬁbrillar aggregates that redistributed throughout the
cytoplasm. (Panels E and F) IF analysis of MxA expression in VMxA cells; independent clones VA9 (panel E) and VA3 (panel F). MxA is detected with mouse anti-MxA or
mouse anti-cmyc antibodies and visualized with Alexa Fluor 488.
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The WNVKUNE and prM proteins are glycoproteins that comprise
the ﬂavivirus envelope (Lindenbach and Rice, 2001). As can be
observed in Fig. 3A, no co-localization was observed between MxA
and the WNVKUN E and prM proteins, whereas an almost perfect
co-localization was observed between MxA and WNVKUN C in
these cells (Fig. 3A a–c). Both antibodies co-labeled the large
ﬁbril aggregates in the cytoplasm. There was clear evidence that
both the MxA and WNVKUN C proteins were redistributed in the
Fig. 3. (A) MxA speciﬁcally co-localizes with the WNVKUN C protein but not the other structural proteins E and prM. BHK tet-KUNCprME cells were electroporated with
KUNrepMxA and KUNrepβ-gal RNA. 48 h post-electroporation the cells were ﬁxed for IF analysis. Co-localization of MxA with the WNVKUN C protein (panels a–c) but
not with the other structural protein E (panels d–f) or prM (panels g–i) is observed. MxA was detected with antibodies raised against the epitope tag cmyc and Texas Red
whereas the WNVKUN proteins were detected with monospeciﬁc antisera and Oregon Green. (B) Immunoﬂuoresecence analysis of replicon electroporated tet-KUNCprME
BHK cells reveals co-localization and redistribution of the expressed MxA protein with WNVKUN C, whereas expressed β-gal had no effect on C localization. WNVKUN C was
detected with mono-speciﬁc antibodies and visualized with Oregon Green, whereas the expressed MxA and β-gal were visualized via their respective antibodies and
Texas Red.
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transfected cells (see also Fig. 4). This was in stark contrast to the
distribution of C protein in β-gal expressing cells whereby
WNVKUN C was localized diffusely within the cytoplasm and
within the nucleolus (Fig. 3B d–f), as we have previously described
(Westaway et al., 1997a, 1997b).
To clarify the exact localization of MxA and WNV C we
performed additional IF investigations on the large aggregates by
confocal microscopy (Fig. 4). As can be observed a majority of the
labeling for both proteins was co-incident, as visualized by the
yellow hue in panels C and F. The tubular structures were
distributed over the entire cytoplasm, but not in the nucleus of
KUNrepMxA-transfected tet-KUNCprME BHK cells. The presence
of these large MxA/C structures in the cytoplasm did affect normal
cell morphology to some degree as swelling of the cells and some
syncitium formation could be observed (Figs. 2 and 4).
These observations suggested that the expression of MxA from
the WNVKUN replicon induced the sequestering of WNVKUN C to
tubular aggregates possibly contributing to the reduced secretion
of infectious KUNrepMxA VLPs. However after exhaustive experi-
mental approaches we have been unsuccessful in conclusively
demonstrate a direct interaction between the expressed MxA and
WNVKUN C protein, however this part of our continuing studies.
This interaction appears to be a speciﬁc active process though as
both the WNVKUN C and the MxA proteins are altered in their
distribution under these conditions, whereas the WNVKUN E and
prM proteins remain unaffected.
Ultrastructural and electron tomographic analysis reveals that the
MxA/C aggregates are composed of homologous hollow tubes
Ultrastructural analyses were subsequently performed to deter-
mine the structural nature of the MxA/C aggregates. As can be
observed in Fig. 5, the ﬁbrillar aggregates were distinct from
membranous structures induced during replication of WNVKUN
(paracrystalline arrays [PC] and vesicle packets [VP] in Fig. 5A). The
MxA/C aggregates appeared as clusters of tubules in proﬁle but
with an apparent consistent width of approximately 30 nm in
diameter (Fig. 5B). These tubular bundles were decorated with
anti-MxA antibody–protein A gold complexes (Fig. 5C and D).
Immunogold-labeling with antibodies to WNVKUN C and MxA
conﬁrmed that, in addition to MxA these structures also contained
C (Fig. 5E and F). The tubular bundles visualized in the KUN-
repMxA transfected tetKUN-CprME BHK cells displayed remark-
able similarity to structures induced during MxA speciﬁc
sequestration of the LACV N protein (Kochs et al., 2002; Reichelt
et al., 2004). Such similarity in structure suggests that the
sequestering of viral capsids into tubular bundles may be a
conserved structural function for MxA during virus infection.
However we as stated above we are currently unable to show a
direct interaction between MxA and C.
Subsequently, we performed electron-tomography on these
structures to provide a greater spatial relationship in the structural
arrangement of these tubes within transfected cells. As seen in
Fig. 6 these tubes are closely aligned in parallel to each other and
clearly represent hollow tubes. In some instances direct connec-
tions between the tubular elements was apparent, however the
nature of this connection is unknown. Panels 6E and F show two
independent stereo images of the MxA/C bundles and movies are
additionally presented (see supplementary data).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.virol.2013.10.005.
The results described here imply that under “natural condi-
tions” WNVKUN appears to evade the capacity of MxA to sequester
the C protein. We postulate that this is due to a rapid and
Fig. 4. MxA and WNVKUN C protein co-localize in tubular structures in the cytoplasm of a WNV packaging cell line. BHK tet-KUNCprME cells were electroporated with
KUNrepMxA RNA. Confocal IF analysis performed at 48 h post-electroporation reveals co-localization (yellow hue in panels c and f) of the expressed MxA protein (panels a
and d) with the WNVKUN C protein (panels b and e). MxA was detected with antibodies raised against the epitope tag cmyc and Alexa Fluor 594 whereas the WNVKUN C was
detected with a monospeciﬁc antiserum and Alexa Fluor 488.
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presumably compartmentalized assembly process, whereby no
free capsid is observed within WNVKUN-infected cells (Mackenzie
and Westaway, 2001). In the situation described here the separa-
tion of replication (using replicon RNA) and assembly (via supply-
ing structural proteins in trans in an inducible stable cell line)
provides a “window of opportunity” for MxA to promote the
sequestering of the WNVKUN C protein.
MxA retargeted to the endoplasmic reticulum co-localizes
with WNVKUN capsid during infection
Based on the results described above, we hypothesized that
under favorable conditions MxA can induce the sequestering of
the WNVKUN C protein, thus restricting the production of infec-
tious virus particles. To examine this hypothesis further we
investigated whether a retargeted MxA (i.e. from its normal
cytoplasmic localization to the ER) would allow MxA to detect
WNVKUN capsid normally observed in the ER during virus assem-
bly (Mackenzie and Westaway, 2001) and thus inhibit production
of virus particles. Thus we obtained cDNA expression cassettes of
MxA that had been tagged with an ER retention signal based on
the cytochrome p450 targeting sequence (Ahn et al., 1993) (MxA
[p450]), an ER retention signal based on the Hepatitis C virus NS5A
retention sequence (Brass et al., 2002) (MxA[NS5A]) or a GTPase
defective MxA impaired in its antiviral activity (Ponten et al., 1997)
(MxA[T103A]). As seen in Fig. 7, all of the MxA constructs were
efﬁciently expressed after transfected in Vero cells. However, only
the MxA(p450) appeared to localize to protein disulﬁde isomerize
(PDI)-positive ER membranes (Fig. 7C). Previously we and others
have shown that expression of wild-type MxAwas associated with
ER membranes positive for Syntaxin-17 (Stertz et al., 2006), but
not for PDI (Fig. 7A; and Hoenen and Mackenzie unpublished
observations) and that the WNVKUN replication complex is formed
on ER membranes positive for PDI (Gillespie et al., 2010). We
subsequently assessed the subcellular localization of these MxA
constructs and the WNVKUN C after transfection and subsequent
superinfection with WNVKUN. As can be observed MxA, MxA
(T103A) and MxA(NS5A) showed distinct localization patterns to
that of WNVKUN C in infected cells (Fig. 7B and D). In all of the
cases the WNVKUN C was observed to localize within the cyto-
plasm and the nucleolus, as previously described (Westaway et al.,
1997a, 1997b). In stark contrast, the MxA(p450) construct dis-
played identical localization to that of WNVKUN C with a drastic
redistribution of both proteins within the perinuclear region
(compare the MxA negative cells in the middle panel of WNVKUN
and pcDNA3-MxA(p450) in Fig. 7C). The WNVKUN C protein was
Fig. 5. Ultrastructural analysis of the MxA-capsid aggregates reveals the presence of organized bundles of hollow tubes. Panels A and B, Resin sections from tet-KUNCprME
BHK cells electroporated with KUNrepMxA RNA. In panel A the MxA-C bundles are observed adjacent to the virus-induced membranes paracrystalline arrays (PC) and vesicle
packets (VP) involved in WNV replication. Panel B shows a transverse section of a MxA-C bundle, indicating the bundle consists of hollow tubes. Panels C and D; Immunogold
labeling of cryosections with anti-MxA antibodies detected with 10 nm protein A gold. The anti-MxA antibodies decorate the MxA-C bundles that also appear to align near
the rough endoplasmic reticulum (rER). Panels E and F; dual-immunogold labeling of cryosections with anti-MxA (detected with 10 nm gold) and anti-C antibodies (detected
with 5 nm gold) indicate that both proteins are co-localized to the MxA-C bundles. Arrows in panels E and F highlight the anti-C labeling due to the small size of the
conjugated gold particles. Magniﬁcation bars represent 200 nm in panels C, D and E; 500 nm in panels B and F and 1 μm in panel A.
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observed to be retained with MxA within the ER (presumably within
PDI-positive subdomains) and none was observed within the nucleus/
nucleolus. This is very signiﬁcant since we previously showed that
WNVKUN replication and assembly are also closely linked to PDI-
positive membranes derived from the ER (Gillespie et al., 2010;
Mackenzie, 2005; Mackenzie et al., 1999; Mackenzie and Westaway,
2001). We did observe some minimal co-localization between
WNVKUN C and MxA(NS5A) (Fig. 7D), however this did not appear
to alter the distribution of MxA or WNVKUN C protein.
Thus, it appears that if directed to the appropriate cellular
location the antiviral MxA protein can access viral components
that are normally “hidden” or not accessible to the antiviral
properties of MxA. In this case it is apparent that MxA can promote
the retention of the WNVKUN C protein within the ER of infected
cells when it is retargeted to ER.
Retargeting of MxA to the ER can prevent the production of infectious
WNVKUN infectious particles
To extend our observations further we co-transfected Vero cells
with a WNVKUN infectious cDNA clone pKUN1 (Khromykh et al., 2001)
and different MxA constructs and assessed their ability to prevent the
production of infectious particles. We choose to utilize pKUN1 during
these experiments as we have observed the co-transfection of two
separate plasmids generally results in both plasmids being taken up by
the same cell. Superinfectionwith WNVKUN would have provided high
background due to the approximate 5–10% transfection rate of the
MxA constructs, thus any observed differences would be compro-
mised. As can be seen in Fig. 8A the transfection of pKUN1 alone
resulted in the production of infectious particles to approximately
1104 pfu/ml after 72 h. Co-transfection of pKUN1 and MxA or MxA
(T103A) also resulted in the production of infectious virus particles of
equivalent titers (approximately 7.5103 pfu/ml). Co-transfection of
pKUN1 with the MxA(NS5A) construct resulted in a moderate
decrease in the release of infectious particles (approximately
4103 pfu/ml) but a drastic reduction was observed during co-
transfection of pKUN1 and MxA(p450) which almost completely
impaired infectious virus release (approximately 400 pfu/ml) and
completely inhibited the spread of infectious virus particles (Fig. 8B).
These results indicate that WNV is susceptible to the antiviral
effects of MxA but has evolved mechanisms to prevent an inter-
action between MxA and WNV; namely hiding replication
Fig. 6. 3-D reconstruction of the MxA-C tubular bundles. MxA-C bundles observed in a 300 nm thick section prepared by conventional chemical ﬁxation and embedding.
Panels A–D; Different stages of the 3-D reconstruction of the MxA-C tubes using the Amira 4.1 software from Mercury Computer Systems. The 3-D model was constructed
using median ﬁltering and automatic threshold segmentation. Panels E-F; provide the 3-D reconstruction in stereo. (Movie ﬁles of the 3-D reconstruction are provided as
Movies S1–3 in Supplementary material).
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components in membranous structures which we showed pre-
viously (Hoenen et al., 2007) as well as seemingly rapid assembly
process whereby the WNV C is compartmentalized within ER
membranes and is not released to the cytoplasm where it can be
targeted by MxA.
Discussion
In this paper we present compelling evidence for an evolu-
tionary means of immune evasion by the ﬂavivirus WNVKUN. Our
results indicate that in accordance to the proposed role of the IFN-
induced MxA to recognize and bind viral nucleocapsids (particu-
larly from negative strand viruses), the intrinsic antiviral ability of
MxA to sequester WNVKUN C protein and hamper production of
infectious virus particles under suitable conditions. We show that
this situation occurs when MxA is expressed from a WNVKUN
replicon within the tetKUN-CprME BHK packaging cell line, where
the events of viral RNA replication and assembly occur in trans
rather than in cis, as normally during virus infection. More
strikingly, we also observed a potent antiviral effect of MxA when
it was targeted to speciﬁc regions within the ER even during
infection. We believe these results indicate that MxA has the
capacity to recognize and sequester the WNVKUN C protein with
detrimental effects on the production of infectious virus particles.
However, we suggest that during infection the compartmentalization
of replication components (Hoenen et al., 2007) and a rapid assembly
process on virus-induced membrane structures (Mackenzie and
Westaway, 2001) prevents surveillance and thus the antiviral effects
of MxA.
Recent structural data has shown that MxA oligermerizes into
multimeric ﬁlamentous or ring-like structures (Daumke et al.,
2010; Gao et al., 2010). The predicted substrate binding loop of
MxA points to the centre of the ring, where it is thought to interact
with viral or membrane target structures (Gao et al., 2011). A
straightforward theory suggests that these oligermeric rings form
around the tubular structure of viral nucleocapsids. Subsequent
conformational changes upon GTP binding and/or hydrolysis may
lead to the immobilization, degradation or redistribution of the
nucleocapsid, thereby inhibiting viral replication. We have demon-
strated that MxA and the WNVKUN C protein form tightly packed
bundles of hollow tubes in the cytoplasm of the WNVKUN packa-
ging cell line (Figs. 4–6). These structures are visually analogous to
those induced by MxA interacting with the LACV N protein (Kochs
et al., 2002). The ﬁbrils observed by Kochs et al. Kochs et al. (2002)
are strikingly similar in their appearance to the structures we
observed here, strongly implicating a similar mode of action of
MxA in sequestering both the Flavivirus C and Bunyavirus N
Fig. 7. Retargeting MxA to the ER can induce interaction with the WNVKUN C protein during wild-type virus infection. Vero cells were transfected with wild-type
MxA (pcDNA3-MxA; panel A), a MxA containing a GTPase mutation (pcDNA3-MxA(T103A); panel B), MxA incorporating the ER localization signal of cytochrome
p450 (pcDNA3-MxA(p450); panel C) or MxA with the ER localization signal of the Hepatitis C virus NS5A protein (pcDNA3-MxA(NS5A); panel D). The transfected
cells were subsequently infected with WNVKUN for 24 h and localization of MxA was compared by confocal IF analysis with that of the ER resident protein disulﬁde
isomerize (PDI; in green) and visualized with Alexa Fluor 594 or the WNVKUN C protein (in red) and visualized by Alexa Fluor 488. Co-localization between WNVKUN C protein
and MxA(p450) is most strikingly observed in the lower merged image in panel C. Some minimal co-localization was also observed between WNVKUN C and MxA(NS5A) in
panel D.
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proteins. However, after exhaustive attempts we have not been
able to convincingly show a direct interaction between MxA and
WNVKUN C protein. At this point we cannot determine the
mechanism that exists to promote the formation of the MxA/C
bundles but it must be due to protein-protein interactions,
perhaps indirect involving a cellular protein. However, it is inter-
esting to note that both WNVKUN C and LACV N proteins undergo
oligomerization themselves during infection (Alfadhli et al., 2001;
Dokland et al., 2004; Kaukinen et al., 2001). Although it has not yet
been determined whether MxA recognizes the oligomeric state of
WNVKUN C, the induction of the tubular bundles is clearly
dependent on an interaction between MxA and C, as neither
protein by itself induces such a structural state independently.
These bundles do not interfere with WNVKUN RNA replication
per se, as we did not observe any differences in the amount of viral
RNA or protein produced from the KUNrepMxA replicon when
compared with KUNrepβ-gal. Additionally, there was no effect on
the induction of characteristic membrane structures known to
facilitate efﬁcient WNV replication. The only apparent effect
appears to be on the ability of C to incorporate into newly forming
virus particles. Interestingly, in Hepatitis B (HBV) infected cells
MxA has been shown to inhibit capsid assembly, however a direct
interaction between the HBV capsid protein (HBcAg) and MxA has
been elucidated (Li et al., 2012). HBcAg forms complexes with MxA
via a central interacting domain and independent of additional
HBV viral components. This results in the immobilization of HBcAg
in the cytoplasm and hinders early capsid formation.
Our ultrastructural and tomographic analyses reveal that the
MxA/C bundles are organized into hollow tubes of 30 nm in
diameter (Fig. 6). Longitudinal and cross-sectional analyses reveal
the ordered arrangement of these bundles. The bundles are
constant in their diameter and appear ﬂexible as curves are also
observed in some sections. The tomographic analyses additionally
revealed that the individual tubes may be connected to each
other, although currently the nature of these connections in not
understood.
One of the major differences between the Flavivirus and
Bunyavirus replication cycles is the intracellular sites of replication
and assembly. Bunyavirus assembly is observed to occur within
Golgi cisternae (Salanueva et al., 2003), a process that is mediated
via the Golgi targeting and retention signals within the virion
glycoproteins (Overby et al., 2007; Shi et al., 2007). Thus the
formation of the virion occurs via budding of the nucleocapsids
(NC) into the lumen of the Golgi stacks incorporating the surface
glycoproteins during the process. For this to occur, a pre-formed
NC is more than likely present within the cytoplasm that must
transit to the Golgi apparatus for assembly. It is logical to assume
that this transport event offers MxA an opportunity to identify and
sequester the Bunyavirus nucleocapsids during infection. Addition-
ally, the intracellular site of Bunyavirus RNA replication has been
extensively studied (Fontana et al., 2008) which has revealed, that
again in contrast to WNVKUN, that the replication complex (RC) is
not necessarily membrane encased. These two contrasts could
explain why ectopic expression of MxA can prevent Bunyavirus but
not Flavivirus infection in cells.
For effective viral infection the invading virus must disable the
host's immune response. For most viruses their major objective is
to disable both IFN-production and signaling. If this can be
achieved then it is highly likely that antiviral proteins like MxA
will not be produced. Both Bunyaviruses and Flaviviruses encode
factors and/or processes that subvert the IFN system (Ambrose and
Mackenzie, 2011; Blakqori et al., 2007; Diamond, 2003; Erika et al.,
2005; Keller et al., 2007; Malet et al., 2007; Weber et al., 2002). For
Bunyaviruses the IFN antagonist appears to be the viral protein NSs
and like other negative-sense RNA viruses, their approach appears
solely to inhibit IFN production and signaling. Whereas, most (if
not all) of the WNVKUN non-structural proteins appear to prevent
IFN-mediated events (Liu et al., 2004, 2006, 2005), the manipula-
tion of intracellular cholesterol (Malet et al., 2007), stimulation of
the unfolded protein response (Ambrose and Mackenzie, 2011)
and the induction of membranous structures that house the
WNVKUN RC also contribute to Flavivirus immune evasion
(Hoenen et al., 2007). These approaches appear to separate distinct
strategies used by negative-sense and positive-sense RNA viruses
to avoid the immune response.
The most signiﬁcant ﬁnding we report is the ability of an ER-
retargeted MxA to retain WNVKUN C protein within the ER during
wild-type infection and signiﬁcantly impair the production and
spread of infectious virions. The most striking observation is that
only the MxA containing the cytochrome p450 targeting sequence
could drastically inhibit WNVKUN virion production, whereas MxA
tagged with the HCV NS5A retention signal could only moderately
reduce virus production. One of the major differences between
these two constructs is their localization with regard to PDI-
positive ER membranes (see Fig. 7). Although both are targeted
to the ER it suggests that the presence of distinct sub-domains
within the ER that contain different resident host proteins, in this
case PDI. Previously we have shown that WNVKUN RNA replication
Fig. 8. MxA(p450) can inhibit the production and spread of infectious WNVKUN
virions. Vero cells were co-transfected with cDNA expression plasmids encoding for
the full length WNVKUN infectious genome (pKUN1) and pcDNA3-MxA, pcDNA3-
MxA(T103A), pcDNA3-MxA(p450) or pcDNA3-MxA(NS5A). Spread of infectious
WNVKUN was assessed by harvesting the tissue culture medium at different time
post-transfection and analysis by plaque assay (Panel A); or transfected cells were
ﬁxed for IF analysis using polyclonal antibodies raised against the WNVKUN NS3
protein detected with Alexa Fluor 488 and MxA visualized by Alexa Fluor 594
(Panel B).
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and assembly are associated with PDI-positive membranes
(Mackenzie et al., 1999; Mackenzie and Westaway, 2001). There-
fore, we suggest that WNVKUN assembly may not occur throughout
the entire ER but be conﬁned to speciﬁc regions within the ER
membrane platform, identiﬁed with PDI. This observation has
signiﬁcant implications as to where ﬂaviviruses assemble within
infected cells.
With the exception of a few reports with the Sarafend strain of
WNV (Ng et al., 1994, 2001, 1994) free WNV nucleocapsids are seldom
observed in the cytoplasm of infected cells. We have previously shown
that WNVKUN assembly is closely associated with virus-induced
membrane structures with deﬁned roles in the virus lifecycle
(Mackenzie and Westaway, 2001). Our studies have indicated that
formation of the WNVKUN virion occurs on the cytoplasmic face of the
ER, with acquisition of the lipid envelope occurring via “budding” into
the lumen of the ER. Subsequent maturation and release occurs via the
secretory pathway. The lack of free WNVKUN C in the cytoplasm might
suggest that WNVKUN assembly is a rather fast and efﬁcient process
leaving minimal opportunity for host derived antiviral proteins like
MxA to interfere with the formation of virions. When WNVKUN
replication and assembly occur in trans, as is the case in the WNVKUN
replicon packaging system we have shown that now MxA has a
negative effect on the assembly process by promoting the sequestering
of C in cytoplasmic structures and thereby reducing the formation of
new virions. In contrast to infection with replicon VLPs, following
infection with WNVKUN the MxA protein localizes to the cytoplasm of
cells where it can associate with syntaxin-17 positive membranes
(Stertz et al., 2006) and does not inhibit WNV assembly. Retargeting
MxA to the PDI positive sites of the ER via the MxAp450 variant
resulted in a strong inhibition of newWNV production. Together these
results suggest that the proposed rapid assembly process of WNV on
speciﬁc sites of the ER might provide protection from the host
surveillance system to inhibit the formation of virus particles.
An important consideration that has emerged from this study is
the potential application of re-targeted MxA for antiviral therapy.
Throughout this report we have described how WNVKUN has
evolved to evade the antiviral properties of MxA via its replication
and assembly processes. However, we have shown that delivery of
an ER-directed MxA can impair the production of infectious virions
during WNVKUN infection. Our future studies will explore the
potential use of MxA as an antiviral agent to prevent infection
from the pathogenic family of viruses.
Materials and methods
Cells
BHK21 and Vero cells were maintained in Dulbecco's modiﬁed
minimal essential medium (DMEM, Invitrogen) supplemented
with 5% fetal bovine serum (FBS, Invitrogen) at 37 1C in a 5% CO2
incubator. A WNVKUN trans-packaging BHK21 cell line (tetKUN-
CprME; (Harvey et al., 2004)); was additionally supplemented
with G418 (100 mg/ml) and Puromycin (3 mg/ml) for mainte-
nance, and with Doxycycline (5 mg/ml) to suppress expression of
WNVKUN structural proteins when not required. Vero cell lines
stably expressing the human MxA protein, (VMxA, clones A3 and
A9; (Frese et al., 1995)) were kindly provided by Georg Kochs
(Universisty of Freiberg, Freiburg, Germany) and were maintained
in DMEM supplemented with 5% FBS and containing G418.
Reagents
The SP6KUNrep5 WNVKUN replicon (Varnavski et al., 2000) was
kindly provided by Replikun Biotech Pty Ltd. Mouse and rabbit anti-
MxA antisera and the pcDNA-MxA, pcDNA-MxA(T103A), pcDNA-MxA
(p450) and pcDNA-MxA(NS5A) cDNA expression plasmids were kindly
provided by Georg Kochs (Universisty of Freiburg, Freiburg, Germany).
Mouse anti-prM monoclonal antbodies and rabbit anti-E polyclonal
antibodies were generously provided by Dr Roy Hall (University
of Queensland, Brisbane, Australia). A rabbit antisera raised against
the N-terminus of the MVE capsid protein was kindly provided by
Dr Mario Lobigs (Australian National University, Canberra, Australia).
Rabbit polyclonal sera (3G3) raised to the WNV C protein were
obtained from Dr Tom Hobman (University of Alberta, Edmonton,
Canada). Rabbit anti-WNVKUN capsid and NS3 polyclonal antibodies,
and mouse monoclonal anti-WNVKUN NS1 antibodies have been
described previously (Westaway et al., 1997a, 1997b). Mouse anti-
protein disulﬁde isomerize (PDI) was purchased from Merck Calbio-
chem (San Diego, CA, USA).
Construction of SP6KUNrep5MxA
Total cellular RNA was isolated from IFN-α stimulated A549
cells. cDNA for MxA-cmyc was obtained by reverse transcription
and PCR utilizing speciﬁc primer pairs (MxA Forward:
CGACGCGTCGATGGTTGTTTCCGAAGTGGAC; MxA Reverse: GGACG-
CGTTTACAGATCCTCTTCTGAGATGAGTTTTTGTTCACCGGGGAACTG-
GGCAAG). The reverse primer incorporated the cmyc epitope into
the C-terminus of the derived MxA sequence. The resulting MxA-
cmyc PCR product was subsequently cloned into SP6KUNrep5
(derived from pKUNrep4 with the CMV promoter changed to a
SP6 promoter and a deletion of the puromycin resistance gene,
(Varnavski et al., 2000)) utilizing a unique Mlu1 site.
In vitro transcription and electroporation
All replicon templates were linearized with XhoI (New England
BioLabs) and puriﬁed using Phenol/Chloroform extraction and
ethanol precipitation. In vitro RNAs were transcribed using 1 μg
linearized DNA template using established methods previously
described (Khromykh et al., 1998; Khromykh and Westaway, 1997).
Brieﬂy, tetKUN-CprME BHK cells (2106/ml) were mixed with
20 μg RNA in a 0.2 cm cuvette (Biorad) and pulsed twice with a
10 s interval using a Biorad Genepulser II (1 Ω, 25 μF, 1.5 KV).
Cells were left on ice for 5 min post electroporation, resuspended
in cell culture media, seeded, and incubated for various periods for
examination of RNA replication and virus like particle (VLP)
production. VLP titers in culture ﬂuids from electroporated cells
were determined by infecting new cells and immunoﬂuorescent
analysis with anti-NS1, anti-cmyc, or anti-β-gal antibodies.
Immunoﬂuorescence (IF) analysis
tetKUN-CprME BHK cell monolayers on coverslips were elec-
troporated or infected with replicon VLPs at 5 m.o.i. and incubated
at 37 1C for different time periods. The cells were subsequently
washed with PBS and ﬁxed with 4% paraformaldehyde (ProSci-
Tech, Kirwan, Australia) for 10 min at 20 1C and permeabilized
with 0.1% Triton X-100 in 4% paraformaldehyde for an additional
10 min at 20 1C; the cells were washed with PBS and aldehyde
groups were quenched with 0.2 M glycine in PBS and additionally
washed twice with PBS before incubation with antibodies. Alter-
natively tetKUN-CprME BHK electroporated or infected cells were
ﬁxed with 1:1 mixture of acetone and methanol and incubated at
20 1C for 10 min before washing with PBS. Primary and second-
ary antibodies were incubated within blocking buffer (PBS con-
taining 1% BSA) and washed with PBS containing 0.1% BSA
between incubation steps. After a ﬁnal wash with PBS the cover-
slipis were drained and mounted onto glass slides with a quick dry
mounting medium (United Biosciences, Brisbane, Australia) before
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visualization on a Zeiss Axiophot 2 IF microscope. Images were
collected using a Zeiss AxioCam MRm digital camera and Axiovi-
sion AC software before processing for publication using Adobe
Photoshop software.
Quantitative real-time PCR
Primers (KUNV F, TCAAGAATAACTTGGCGATCCA; KUNV R,
TCACCTAGGACCGCCCTTT; RPL13A F, CTCAAGGTCGTGCGTCTGAA;
RPL13A R, CTGTCACTGCCTGGTACTTCCA) were designed using the
Primer Express software (Applied Biosystems) and amplicon
length kept constant to allow accurate comparisons between PCR
products. Total cellular RNA was extracted from cells via lysis in
TriZol RNA lysis reagent (Invitrogen) according to manufacturers'
instructions and quantiﬁed at 260 nm absorbance before treat-
ment with RQ1 DNAse (Promega) at 37 1C for 30 min to remove
DNA contamination. Reaction was stopped by addition of Stop
Solution (Promega) and heat inactivation at 65 1C for 15 min. cDNA
was generated from 1 mg of each sample using Superscript III RT
(Invitrogen) and the reverse primers at 2 mM concentrations as
indicated by the manufacturers. RT reactions were diluted to
200 mL, and 5 mL of each reaction was ampliﬁed using SYBR
GreenER qPCR Supermix (Biorad), on Biorad iCycler PCR cycling
machine with the following conditions: 95 1C for 10 min, then 45
cycles of 95 1C for 15 s, 60 1C for 60 s using the primers listed
above. The mRNA levels of WNVKUN genome were quantiﬁed by
comparison of CT (threshold cycle) values to the internal control
RPL13A, and fold induction calculated from a mock sample using
theΔΔCT equation [fold induction ¼2\widehat(ΔCT(target)ΔCT
(mock))]. Collected data were then presented using Graphpad PRISM
software and imported into Adobe Photoshop.
Western blotting
VLP-infected or uninfected cells were lysed in 1 SDS-PAGE
loading buffer and proteins were separated on 4–12% precast Tris-
Bis polyacrylamide gels (Invitrogen). The proteins were subse-
quently transferred to an Hybond-ECL nitrocellulose membrane
(Amersham Biosciences Corp, Piscataway, NJ, USA) using the
Biorad wet-transfer blotting module. The membrane was subse-
quently blocked with 5% Skim Milk Powder (Diploma) in PBS
containing 0.1% Tween-20 at room temp. Incubation with the
appropriate antibodies was performed in blocking buffer on a
rotating wheel overnight at 4 1C. The bound antibodies were
subsequently visualized with species-speciﬁc IgG conjugated to
Alexa Flour 680 (Molecular Probes) or IRDye 800CW (Rockland
Incorporated)- and the LI-COR Odyssey scanner. The resulting
images were digitally scanned and processed in Adobe Photoshop
for publication.
Electron microscopy
For resin embedding cells were ﬁxed with 3% glutaraldehyde in
0.1 M cacodylate buffer for 2 h at room temperature. Cells were
washed several times in 0.1 M cacodylate buffer followed by
ﬁxation with 1% OsO4 in 0.1 M cacodylate buffer for 1 h. After
washing of the cells in 0.1 M cacodylate buffer, specimens were
dehydrated in a graded acetone series. And subsequently inﬁl-
trated with EPON resin and polymerized in molds for 2 days at
60 1C. 50–60 nm ultrathin sections were cut on a Leica Ultracut
ultramicrotome using a Diatome diamond knife and collected on
formvar-coated copper mesh grids. Before viewing in a JEOL 1010
transmision electron microscope cells were post-stained with 2%
aqueous uranyl acetate and Reynold's lead citrate.
Methods for cryoﬁxation, preparation of cryosections and
immunolabelling have been described elsewhere (Mackenzie
et al., 1999; Mackenzie et al., 1996a, 1996b). Brieﬂy, VLP-infected
tetKUN-CprME BHK cells were ﬁxed with 4% paraformaldehyde/
0.1% glutaraldehyde (ProSciTech, Kirwan, Australia) in PBS on ice
for 60 min and subsequently embedded within a 10% gelatin block
before post-ﬁxing with 1% paraformaldehyde in PBS. The sample
blocks were infused with a mixture of sucrose and polyvinylpyr-
rolidone and mounted onto cryostubs (Leica) for cryo-sectioning.
Ultrathin cryosections (55 nm) were cut with a Diatome Cryo-P
diamond knife and retrieved from the cryo-chamber with a
droplet of 14:1 2.3 M sucrose/2% methylcellulose. The recovered
sections were subsequently immunolabelled with the appropriate
antibodies and protein-A gold (Utrecht University, Utrecht, The
Netherlands) and contrasted with 1.8 M methylcellulose contain-
ing 0.4% uranyl acetate. The sections were then viewed on JOEL
1010 transmission electron microscope and images were captured
on a MegaView III side-mounted CCD camera (Soft Imaging
Systems, USA) and processed for publication in Adobe Photoshop.
Electron tomography
Ribbons of thin (40–60 nm) or thick (300–400 nm) sections
were cut on a microtome (Leica-Microsystems) for conventional
2D survey at 80–100 keV to assess the quality of cell preservation
and for 3D studies by ET at 300 keV on Tecnai T12 and F30
microscopes, respectively (FEI Company). Thick sections were
collected onto formvar-coated copper (21 mm) slot grids (Elec-
tron Microscopy Sciences) and post-stained with 2% aqueous
uranyl acetate (UA) and Reynold's lead citrate followed by carbon
coating. To facilitate the image alignment that is required for the
subsequent image reconstruction step, a suspension of 10 nm gold
particles was layered on top of the thick sections as ﬁducial
markers.
For tomography and 3D reconstruction tilt series were obtained
at 2 1 intervals over a range of 120 1 about two orthogonal axes.
The tilt series were aligned by means of the ﬁducial markers and
dual axis 3-D density distributions (tomograms) were calculated
using IMOD software from the Boulder Laboratory for 3-D Electron
Microscopy of Cells (http://bio3d.colorado.edu/imod/) (Ershov
et al., 1981). Images of 3D reconstructions were produced using
the Amira 4.1 software from Mercury Computer Systems.
Plaque assay
Plaque assays were performed in 6-well plates by infecting 60%
conﬂuent monolayers of Vero cells with dilutions of virus-
containing culture ﬂuids for 60 min. Cells were overlaid with
2 ml of media containing 70% DMEM, 2.5% FBS, 15 mM sodium
hydrogen carbonate, 5 U Penicillin–Streptomycin, 25 mM HEPES,
2 mM Glutamax, 0.35% low melting point agarose, and incubated
for 4 days at 37 1C with 5% CO2. Cells were ﬁxed by adding 1 ml of
20% formaldehyde directly onto the overlay and incubating for
30 min at room temperature. Cells were rinsed with water, stained
with 0.2% crystal violet for 20 min and plaques were counted.
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